These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 3279501

  • 1. Comparative activity of the 4-quinolones.
    Phillips I, King A.
    Rev Infect Dis; 1988; 10 Suppl 1():S70-6. PubMed ID: 3279501
    [Abstract] [Full Text] [Related]

  • 2. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [Abstract] [Full Text] [Related]

  • 3. The comparative in-vitro activity of pefloxacin.
    King A, Phillips I.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
    [Abstract] [Full Text] [Related]

  • 4. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM, Baltch AL, Smith RP.
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [Abstract] [Full Text] [Related]

  • 5. In-vitro activity of newer quinolones against aerobic bacteria.
    Auckenthaler R, Michéa-Hamzehpour M, Pechère JC.
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():29-39. PubMed ID: 2940214
    [Abstract] [Full Text] [Related]

  • 6. [In vitro antibacterial activity of 2 new quinolones: A 56619 (difloxacin) and A 56620. Comparison with pefloxacin, ofloxacin and ciprofloxacin].
    Soussy CJ, Deforges L, Le Van Thoi J, Duval J.
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):759-67. PubMed ID: 3309811
    [Abstract] [Full Text] [Related]

  • 7. The in-vitro activity of CI-934 compared with that of other new 4-quinolones and nalidixic acid.
    King A, Shannon K, Slegg J, Phillips I.
    J Antimicrob Chemother; 1986 Aug; 18(2):163-9. PubMed ID: 3463557
    [Abstract] [Full Text] [Related]

  • 8. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
    King A, Shannon K, Phillips I.
    J Antimicrob Chemother; 1985 May; 15(5):551-8. PubMed ID: 3159712
    [Abstract] [Full Text] [Related]

  • 9. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans].
    Renaudin H, Quentin C, de Barbeyrac B, Bebear C.
    Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430
    [Abstract] [Full Text] [Related]

  • 10. The in-vitro activity of ciprofloxacin compared with that of norfloxacin and nalidixic acid.
    King A, Shannon K, Phillips I.
    J Antimicrob Chemother; 1984 Apr; 13(4):325-31. PubMed ID: 6233249
    [Abstract] [Full Text] [Related]

  • 11. In vitro activities of ciprofloxacin, ofloxacin, norfloxacin and rosoxacin compared with cinoxacin and trimethoprim.
    Digranes A, Dibb WL, Benonisen E.
    Chemotherapy; 1985 Apr; 31(6):466-71. PubMed ID: 2934234
    [Abstract] [Full Text] [Related]

  • 12. In vitro evaluation of A-56619 and A-56620, two new quinolones.
    Barry AL, Thornsberry C, Jones RN.
    Antimicrob Agents Chemother; 1986 Jan; 29(1):40-3. PubMed ID: 2942099
    [Abstract] [Full Text] [Related]

  • 13. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
    King A, Bethune L, Phillips I.
    J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
    [Abstract] [Full Text] [Related]

  • 14. In-vitro antibacterial activity of levofloxacin against hospital isolates: a multicentre study.
    Soussy CJ, Cluzel M, Ploy MC, Kitzis MD, Morel C, Bryskier A, Courvalin P.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():43-50. PubMed ID: 10404337
    [Abstract] [Full Text] [Related]

  • 15. [Sensitivity of obligate anaerobes to ofloxacin, pefloxacin, enoxacin and norfloxacin].
    Dubreuil L, Devos J, Romond C, Bryskier A.
    Pathol Biol (Paris); 1985 May; 33(5):421-5. PubMed ID: 3162143
    [Abstract] [Full Text] [Related]

  • 16. The in-vitro activity of EN 272, a quinolone-7-carboxylic acid, in comparison with other quinolones.
    Neu HC.
    J Antimicrob Chemother; 1985 Jul; 16(1):43-8. PubMed ID: 3862659
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of two new aryl-fluoroquinolone antimicrobial agents, difloxacin (A-56619) and A-56620 compared to that of other antimicrobial agents.
    Hirschhorn L, Neu HC.
    Chemotherapy; 1987 Jul; 33(1):28-39. PubMed ID: 3549179
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of RO 23-6240 (AM-833): a new fluoroquinolone.
    Fass RJ, Helsel VL.
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):293-9. PubMed ID: 3107872
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of aerobic gram-negative blood culture isolates to oxolinic acid, norfloxacin, ciprofloxacin, enoxacin, pefloxacin, ofloxacin and oxo-enoxacin.
    Van der Auwera P.
    Infection; 1986 Apr; 14(3):142-4. PubMed ID: 2942489
    [Abstract] [Full Text] [Related]

  • 20. In-vitro activity of pefloxacin compared with six other quinolones.
    Ligtvoet EE, Wickerhoff-Minoggio T.
    J Antimicrob Chemother; 1985 Oct; 16(4):485-90. PubMed ID: 3864776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.